Shukla SD and Hanahan DJ |
An early transient decrease in phosphatidylinositol 4,5-bisphosphate upon stimulation of rabbit platelets with acetylglycerylether phosphorylcholine (platelet activating factor). |
1983 |
Arch. Biochem. Biophys. |
pmid:6320731
|
Wasserman SI |
Mediators of immediate hypersensitivity. |
1983 |
J. Allergy Clin. Immunol. |
pmid:6193157
|
MacIntyre DE and Pollock WK |
Platelet-activating factor stimulates phosphatidylinositol turnover in human platelets. |
1983 |
Biochem. J. |
pmid:6411067
|
O'Flaherty JT et al. |
5-L-hydroxy-6,8,11,14-eicosatetraenoate potentiates the human neutrophil degranulating action of platelet-activating factor. |
1983 |
Biochem. Biophys. Res. Commun. |
pmid:6403011
|
Haddad ZH and Green A |
State--and dynamics--of the art: a current review. IgE-mediated immediate hypersensitivity reactions: cellular events and pharmacologic mediators. |
1983 |
J Asthma |
pmid:6190793
|
Swendsen CL et al. |
1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine: a novel source of arachidonic acid in neutrophils stimulated by the calcium ionophore A23187. |
1983 |
Biochem. Biophys. Res. Commun. |
pmid:6407484
|
Bessin P et al. |
Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. |
1983 |
Eur. J. Pharmacol. |
pmid:6687572
|
Shukla SD et al. |
Acetylglyceryl ether phosphorylcholine. A potent activator of hepatic phosphoinositide metabolism and glycogenolysis. |
1983 |
J. Biol. Chem. |
pmid:6309795
|
Hallam TJ et al. |
The role of 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (AcGEPC) and palmitoyl-lysophosphatidate in the responses of human blood platelets to collagen and thrombin. |
1983 |
FEBS Lett. |
pmid:6617886
|
Roussi J et al. |
[Success of treatment with a low-molecular-weight heparin fraction in a case of pulmonary embolism complicated by heparin-induced thrombopenia]. |
1983 |
Nouv Rev Fr Hematol |
pmid:6622253
|
Valone FH and Goetzl EJ |
Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC). |
1983 |
Am. J. Pathol. |
pmid:6624880
|
Barradas MA et al. |
The effect of fenfluramine on collagen-induced platelet aggregation in vitro. |
1983 |
Br J Clin Pharmacol |
pmid:6626443
|
Korth R et al. |
1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholines: influence on aggregation and [3H]serotonin release of human thrombocytes. |
1983 |
Chem. Phys. Lipids |
pmid:6627525
|
Moschidis MC et al. |
Phosphono-platelet activating factor I. Synthesis of 1-O-hexadecyl-2-O-acetyl-glyceryl-3-(2-trimethyl ammonium-methyl) phosphonate and its platelet activating potency. |
1983 |
Chem. Phys. Lipids |
pmid:6627527
|
Vargaftig BB et al. |
Convulxin-induced activation of intact and of thrombin-degranulated rabbit platelets: specific crossed desensitisation with collagen. |
1983 |
Eur. J. Pharmacol. |
pmid:6628537
|
Farr RS et al. |
Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor. |
1983 |
Fed. Proc. |
pmid:6628702
|
Denjean A et al. |
Acute effects of intratracheal administration of platelet-activating factor in baboons. |
1983 |
J Appl Physiol Respir Environ Exerc Physiol |
pmid:6629917
|
Myers A et al. |
Glucocorticoid protection against PAF-acether toxicity in mice. |
1983 |
Br. J. Pharmacol. |
pmid:6652344
|
Cervoni P et al. |
Aortic vascular and atrial responses to (+/-)-1-O-octadecyl-2-acetyl-glyceryl-3-phosphorylcholine. |
1983 |
Br. J. Pharmacol. |
pmid:6652348
|
Benveniste J et al. |
The actions of Paf-acether (platelet-activating factor) on guinea-pig isolated heart preparations. |
1983 |
Br. J. Pharmacol. |
pmid:6652376
|
Garcia Gil M and Sanchez Crespo M |
Dansylcadaverine and rimantadine inhibition of phagocytosis, PAF-acether release, and phosphatidylcholine synthesis in human polymorphonuclear leukocytes. |
1983 |
Immunopharmacology |
pmid:6654649
|
Tokumura A et al. |
Biphasic action of platelet-activating factor on isolated guinea-pig ileum. |
1983 |
Lipids |
pmid:6656539
|
Hamasaki Y et al. |
[Effects of platelet activating factor (PAF:AGEPC) on airway and pulmonary vascular constriction of guinea pigs--with special reference to the relation with TXA2]. |
1983 |
Kokyu To Junkan |
pmid:6658209
|
Björk J et al. |
Paf-acether (platelet-activating factor) increases microvascular permeability and affects endothelium-granulocyte interaction in microvascular beds. |
1983 |
Acta Physiol. Scand. |
pmid:6659994
|
Björk J and Smedegård G |
Acute microvascular effects of PAF-acether, as studied by intravital microscopy. |
1983 |
Eur. J. Pharmacol. |
pmid:6662199
|
Yamashita M et al. |
The metabolism of platelet activating factor in platelets and plasma of various animals. |
1983 |
J Toxicol Sci |
pmid:6663653
|
Masugi F et al. |
[Kidney medulla and hypertension, with special reference to antihypertensive lipids]. |
1983 |
Nihon Jinzo Gakkai Shi |
pmid:6663856
|
Mueller HW et al. |
Biosynthesis of platelet activating factor in rabbit polymorphonuclear neutrophils. |
1983 |
J. Biol. Chem. |
pmid:6406476
|
Lee TC et al. |
Stimulation of calcium uptake by 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) in rabbit platelets: possible involvement of the lipoxygenase pathway. |
1983 |
Arch. Biochem. Biophys. |
pmid:6407399
|
Billah MM and Johnston JM |
Identification of phospholipid platelet-activating factor (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid and urine. |
1983 |
Biochem. Biophys. Res. Commun. |
pmid:6407483
|
Chilton FH et al. |
Selective acylation of lyso platelet activating factor by arachidonate in human neutrophils. |
1983 |
J. Biol. Chem. |
pmid:6408071
|
Lecrubier C et al. |
Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin. |
1983 |
Agents Actions |
pmid:6858789
|
Gonzalez-Crussi F and Hsueh W |
Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. |
1983 |
Am. J. Pathol. |
pmid:6859226
|
Camussi G et al. |
Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor. |
1983 |
Am. J. Pathol. |
pmid:6859232
|
Sánchez-Crespo M et al. |
Presence in normal human urine of a hypotensive and platelet-activating phospholipid. |
1983 |
Am. J. Physiol. |
pmid:6859262
|
Lumb RH et al. |
Spontaneous and protein-catalyzed transfer of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) between phospholipid bilayers. |
1983 |
Biochim. Biophys. Acta |
pmid:6860678
|
Suquet CM and Leid RW |
Aggregation of equine platelets by PAF (platelet-activating factor). |
1983 |
Inflammation |
pmid:6862593
|
Blank ML and Snyder F |
Improved high-performance liquid chromatographic method for isolation of platelet-activating factor from other phospholipids. |
1983 |
J. Chromatogr. |
pmid:6863454
|
Simrock R et al. |
[Reversible inhibition of thrombocyte stimulation by acetylsalicylic acid and its role in antithrombotic therapy]. |
1983 |
Klin. Wochenschr. |
pmid:6865264
|
Hadváry P and Baumgartner HR |
Activation of human and rabbit blood platelets by synthetic structural analogs of platelet activating factor. |
1983 |
Thromb. Res. |
pmid:6868019
|
Camussi G et al. |
Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia. |
1983 |
Immunology |
pmid:6339375
|
Billah MM and Lapetina EG |
Platelet-activating factor stimulates metabolism of phosphoinositides in horse platelets: possible relationship to Ca2+ mobilization during stimulation. |
1983 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:6341992
|
Lapetina EG and Siegel FL |
Shape change induced in human platelets by platelet-activating factor. Correlation with the formation of phosphatidic acid and phosphorylation of a 40,000-dalton protein. |
1983 |
J. Biol. Chem. |
pmid:6345519
|
Camussi G et al. |
Inhibitory effect of prostacyclin (PGI2) on neutropenia induced by intravenous injection of platelet-activating-factor (PAF) in the rabbit. |
1983 |
Prostaglandins |
pmid:6346397
|
Iñarrea P et al. |
Platelet-activating factor: an effector substance of the vasopermeability changes induced by the infusion of immune aggregates in the mouse. |
1983 |
Immunopharmacology |
pmid:6347969
|
Satouchi K |
[Platelet activating factor (PAF)--a new chemical mediator of inflammation]. |
1983 |
Seikagaku |
pmid:6350499
|
McGowan EB and Detwiler TC |
Characterization of the thrombin-induced desensitization of platelet activation by thrombin. |
1983 |
Thromb. Res. |
pmid:6356458
|
Weksler BB |
Platelets and the inflammatory response. |
1983 |
Clin. Lab. Med. |
pmid:6360503
|
Machin SJ et al. |
Defective platelet aggregation to the calcium ionophore A23187 in a patient with a lifelong bleeding disorder. |
1983 |
J. Clin. Pathol. |
pmid:6413552
|
Alam I et al. |
Metabolism of platelet-activating factor by blood platelets and plasma. |
1983 |
Lipids |
pmid:6413803
|